World Heart Federation

Butterfly Needles Market Report 2023: Advantages Over Straight Needles Drives Adoption - ResearchAndMarkets.com

Retrieved on: 
Monday, January 30, 2023
Medical Supplies, Health, US Census Bureau International Data Base, World Heart Federation, Blood, Cancer, Hospital, LDL, Vein, Patient, Needle, World Health Organization, Blood transfusion, Trauma, Diabetes, United States Census Bureau, Risk, IV, Application, WHO, Death, Stroke, Shock (mechanics), Survival, Plasma, Growth, Kent, Anti-transglutaminase antibodies, Conditional sentence, Prevalence, Chronic Respiratory Disease, COVID-19, Kidney, Vaccine, Pharmaceutical industry

The "Butterfly Needles Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Application and End User" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Butterfly Needles Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Application and End User" report has been added to ResearchAndMarkets.com's offering.
  • The growth of the global butterfly needles market is driven by the rise in the prevalence of chronic diseases and the advantages of butterfly needles over straight needles.
  • However, the risk associated with butterfly needles stick injuries is hampering the market growth.
  • Based on application, the butterfly needles market is categorized into blood collection, IV rehydration, delivery of medications, venipuncture, and blood transfusion.

COVID-19 Vaccination Linked to Fewer Cardiac Events; First U.S. study to show lower risk in patients following SARS-CoV-2 infection

Retrieved on: 
Monday, February 20, 2023
Journal, Messenger, SARS-CoV-2, MACE, D3M, DOI, Stroke, World Heart Federation, Patient, Health Promotion International, Pfizer, Kidney, Journal of the American College of Cardiology, Icahn School of Medicine at Mount Sinai, Bangladesh Technical Education Board, Splenic infarction, Johnson & Johnson, Obesity, American College of Cardiology, Division, Digestive, COVID-19, Research, Risk, Science, Causality, Department of Medicine – University of Pamplona, Congress, Liver disease, MPH, Korean, American College, Health information management, Lily Chan, MS, Mount Sinai, Doctor of Philosophy, Pharmaceutical industry, Vaccine, Vaccination, Cardiology, Medicine, MD

NEW YORK, Feb. 20, 2023 /PRNewswire-PRWeb/ -- Analyzing the most extensive datasets in the United States, researchers from the Icahn School of Medicine at Mount Sinai have revealed that vaccination against COVID-19 is associated with fewer heart attacks, strokes, and other cardiovascular issues among people who were infected with SARS-CoV-2, the virus that causes COVID-19.

Key Points: 
  • The research letter, "Impact of Vaccination on Major Adverse Cardiovascular Events in Patients with COVID-19 Infection," was published in the Journal of the American College of Cardiology on February 20.
  • The research letter, "Impact of Vaccination on Major Adverse Cardiovascular Events in Patients with COVID-19 Infection," was published in the Journal of the American College of Cardiology on February 20 (DOI: 10.1016/j.jacc.2022.12.006).
  • "To our surprise, even partial vaccination was associated with lower risk of adverse cardiovascular events," said first study author Joy Jiang, an MD/PhD candidate in the lab of Dr. Nadkarni.
  • "Given the magnitude of SARS-CoV-2 infection worldwide, we hope our findings could help improve vaccination rates, especially in individuals with coexisting conditions."

Esperion Announces CLEAR Cardiovascular Outcomes Trial of NEXLETOL® (bempedoic acid) Meets Primary Endpoint

Retrieved on: 
Wednesday, December 7, 2022
Online, Bronchitis, Moyamoya disease, Atrial fibrillation, Simvastatin, Kidney, Cardiovascular disease, National Center for Health Research, Shoulder, Abdominal pain, Mortality, ANN, Pregnancy, Health, ATP, Security (finance), ESPR, Uric acid, Rotator cuff, Drug, Diet, National Center for Health Statistics, Back pain, Pravastatin, Centers for Disease Control and Prevention, Pain, CDC, World Heart Federation, Spasm, Gout, Cholesterol, Lactation, Fetus, Disease, Upper respiratory tract infection, Achilles tendon, Concentration ratio, GA, Growth, CLEAR, Risk, Medical statistics, COVID-19, Patient, Anemia, Tendon rupture, Pharmaceutical industry, Dietary supplement, Hyperuricemia, Bempedoic acid, Death, Esperies

ANN ARBOR, Mich., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the landmark Cholesterol Lowering via Bempedoic acid, an ACL-Inhibiting Regimen (CLEAR) Outcomes trial met its primary endpoint, demonstrating statistically significant risk reduction in MACE-4 in patients treated with 180 mg/day NEXLETOL compared to placebo.

Key Points: 
  • CLEAR Outcomes further strengthens the clinical evidence supporting the role of bempedoic acid for patients.”
    Cardiovascular disease remains the number one killer globallyi.
  • A large proportion of patients at risk for cardiovascular events based on elevated LDL-cholesterol and apolipoprotein b are not adequately treated with existing therapies.
  • Despite recent therapeutic advances, there remains a significant need for new treatment options to help improve long-term cardiovascular outcomesii.
  • Limitations of Use: The effect of NEXLETOL on cardiovascular morbidity and mortality has not been determined.

Global alliance of heart patient organizations unveils new Global Cholesterol Action Plan to prioritize unhealthy cholesterol as a main public health issue

Retrieved on: 
Wednesday, November 30, 2022
Michael (archangel), Human, Stroke, Public health, Cardiology, Science, Organization, Hospital, Risk, Novartis, Policy, Mortality, Cardiovascular disease, Global Malaria Action Plan, Mended Hearts, Action plan, Moyamoya disease, Associazione Italiana Guide e Scouts d'Europa Cattolici, Death, Diet, Coronary artery disease, Smoking, Cholesterol, World Heart Federation, St. Michael's Hospital, Pharmaceutical industry, Dietary supplement, Medical device

GALWAY, Ireland, Nov. 30, 2022 /PRNewswire/ -- The Global Heart Hub has today launched its Global Cholesterol Action Plan to reduce the impact of unhealthy cholesterol levels .

Key Points: 
  • GALWAY, Ireland, Nov. 30, 2022 /PRNewswire/ -- The Global Heart Hub has today launched its Global Cholesterol Action Plan to reduce the impact of unhealthy cholesterol levels .
  • Presented at their annual UNITE Summit , the Action Plan follows and builds upon the World Heart Federation's Cholesterol Roadmap released in October.
  • The Global Heart Hub aims to implement change in the way unhealthy cholesterol levels are prevented and managed at local levels to reduce ASCVD .
  • The new Action Plan outlines four clear goals to ensure unhealthy cholesterol levels are addressed as a public health priority: build alliances, raise public awareness, activate alliances, and improve high cholesterol detection and management.

Global alliance of heart patient organizations unveils new Global Cholesterol Action Plan to prioritize unhealthy cholesterol as a main public health issue

Retrieved on: 
Wednesday, November 30, 2022
Michael (archangel), Human, Stroke, Public health, Cardiology, Science, Organization, Hospital, Risk, Novartis, Policy, Mortality, Cardiovascular disease, Global Malaria Action Plan, Mended Hearts, Action plan, Moyamoya disease, Associazione Italiana Guide e Scouts d'Europa Cattolici, Death, Diet, Coronary artery disease, Smoking, Cholesterol, World Heart Federation, St. Michael's Hospital, Pharmaceutical industry, Dietary supplement, Medical device

GALWAY, Ireland, Nov. 30, 2022 /PRNewswire/ -- The Global Heart Hub has today launched its Global Cholesterol Action Plan to reduce the impact of unhealthy cholesterol levels .

Key Points: 
  • GALWAY, Ireland, Nov. 30, 2022 /PRNewswire/ -- The Global Heart Hub has today launched its Global Cholesterol Action Plan to reduce the impact of unhealthy cholesterol levels .
  • Presented at their annual UNITE Summit , the Action Plan follows and builds upon the World Heart Federation's Cholesterol Roadmap released in October.
  • The Global Heart Hub aims to implement change in the way unhealthy cholesterol levels are prevented and managed at local levels to reduce ASCVD .
  • The new Action Plan outlines four clear goals to ensure unhealthy cholesterol levels are addressed as a public health priority: build alliances, raise public awareness, activate alliances, and improve high cholesterol detection and management.

CLIMATE CHANGE AND HEALTH INEQUITY A DEADLY MIX FOR THE MOST VULNERABLE: WORLD HEART FEDERATION

Retrieved on: 
Wednesday, September 28, 2022
World Heart Federation, Neuroscience, Heart, Group, Health, Disaster, Weather, Lists of diseases, Gaps, Department, Twitter, WHF, Risk, Disease, List of environmental ministries, Climate change, World, Faculty, European Society of Cardiology, Dean, Air pollution, Kidney disease, Growth, Heart failure, Patient, Boehringer Ingelheim, Research and development, Foundation, Cardiovascular disease, WHO, Human, Death, Climate, CVD, Awareness, University, Medicine, Society, Dietary supplement, Agriculture, Pharmaceutical industry, Medical device, Medical imaging, Cardiology, Research

World leaders must step up efforts on the two biggest threats of our time: climate change and global health inequity."

Key Points: 
  • World leaders must step up efforts on the two biggest threats of our time: climate change and global health inequity."
  • Everyone is encouraged to get involved in World Heart Day and to learn more about better heart health.
  • This World Heart Day, they are proud to continue to support the World Heart Federation.
  • [2]In 2022, the World Heart Federation conducted a global pulse survey of 2500 people across 25 countries.

CLIMATE CHANGE AND HEALTH INEQUITY A DEADLY MIX FOR THE MOST VULNERABLE: WORLD HEART FEDERATION

Retrieved on: 
Wednesday, September 28, 2022
World Heart Federation, Neuroscience, Heart, Group, Health, Disaster, Weather, Lists of diseases, Gaps, Department, Twitter, WHF, Risk, Disease, List of environmental ministries, Climate change, World, Faculty, European Society of Cardiology, Dean, Air pollution, Kidney disease, Growth, Heart failure, Patient, Boehringer Ingelheim, Research and development, Foundation, Cardiovascular disease, WHO, Human, Death, Climate, CVD, Awareness, University, Medicine, Society, Dietary supplement, Agriculture, Pharmaceutical industry, Medical device, Medical imaging, Cardiology, Research

World leaders must step up efforts on the two biggest threats of our time: climate change and global health inequity."

Key Points: 
  • World leaders must step up efforts on the two biggest threats of our time: climate change and global health inequity."
  • Everyone is encouraged to get involved in World Heart Day and to learn more about better heart health.
  • This World Heart Day, they are proud to continue to support the World Heart Federation.
  • [2]In 2022, the World Heart Federation conducted a global pulse survey of 2500 people across 25 countries.

Global Balloon Catheter Market Report 2022-2027: Coronary Artery Disease Segment Leads the Market - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 28, 2022
General Health, Health, Medical Devices, Coronary artery disease, WHO, Awareness, World Health Organization, Death, Blood, World Heart Federation, Patient, CVD, Catheter, COVID-19, Balloon catheter, Femoral artery, Prevalence, Circulatory system, Anatomy, Woman, Cardiac catheterization, CAGR, Heart, Trends and Other Diseases, World, Medical tourism, Cholesterol, Diabetes, Moyamoya disease, Conditional sentence, Industry, Radial artery, Atherosclerosis, Cardiovascular disease, Peripheral artery disease, Man, Renewable energy, Pharmaceutical industry, Medical imaging, Health insurance, Growth

The "Global Balloon Catheter Market, Forecast 2022-2027, Industry Trends, Growth, Outlook, Impact of COVID-19, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Balloon Catheter Market, Forecast 2022-2027, Industry Trends, Growth, Outlook, Impact of COVID-19, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • The balloon catheter is mostly utilized to treat heart-related diseases caused due to diabetes, high blood pressure, specifically coronary heart disease, and high cholesterol levels in the blood.
  • They are frequently used in varied applications like Coronary Artery Disease, Peripheral Vascular Disease, and Neurovascular Diseases that require the balloon to occlude the anatomy.
  • In terms of application, the Balloon Catheter market can be segmented into Coronary Artery Disease, Peripheral Vascular Disease, Neurovascular Diseases, and Others Diseases.

AstraZeneca Healthcare Foundation Awards Seven US Nonprofits More Than $900k to Improve Heart Health and Advance Health Equity

Retrieved on: 
Wednesday, September 29, 2021
General Health, Health, Foundation, Other Philanthropy, Philanthropy, Alabama River, Blood pressure, Partnership, CCH, AstraZeneca, Risk, Cardiovascular disease, World Heart Federation, Health, The City, Patient, Pharmacy, YouTube, Disease, Hypertension, Health literacy, Twitter, Death, Heart, Program, Metabolic syndrome, Human, Knowledge, Obesity, Health equity, Education, Self-management, Investor, Foundation, City, American, Conditional sentence, Columbus metropolitan area, Ohio, Pharmaceutical industry, Dietary supplement

The awardee programs are working to advance health equity by increasing participant health screenings; cardiovascular disease prevention and management; nutrition education; access to healthcare and behavioral health services; physical activity and health coaching through health clinics, coalitions and more.

Key Points: 
  • The awardee programs are working to advance health equity by increasing participant health screenings; cardiovascular disease prevention and management; nutrition education; access to healthcare and behavioral health services; physical activity and health coaching through health clinics, coalitions and more.
  • The Wellness Coalition in Montgomery, Ala.; $150,000: HeartLink Improving Cardiovascular Health in the Alabama River Region works to improve the cardiovascular health and health behaviors of uninsured and underinsured adults in Alabamas River Region.
  • The AstraZeneca HealthCare Foundation works to address health disparities in the US through strategic grant-giving and capacity building support for nonprofit organizations.
  • Established in 1993 as a nonprofit charitable organization, the Foundation is a separate legal entity from AstraZeneca Pharmaceuticals with distinct legal restrictions.

Heart Experts Call For Millions To Benefit From Life-Saving Online Services As Telemedicine Rockets

Retrieved on: 
Tuesday, September 28, 2021
Blood pressure, Policy, Telehealth, Diagnosis, Health, World Heart Federation, WHF, Patient, Population, Cardiovascular disease, CVD, AstraZeneca, Boehringer Ingelheim, COVID-19, Pfizer, Cardiology, Industry, Automated ECG interpretation, Pharmaceutical industry

GENEVA, Sept. 28, 2021 /PRNewswire/ -- On World Heart Day, 29 September 2021, the World Heart Federation (WHF) is calling on the international community to bring digital cardiovascular health services to millions worldwide. COVID-19 has seen an explosion in telemedicine, with a 40%1 jump in the world's richest countries. WHF believes this digital transformation presents a pivotal opportunity for millions living with cardiovascular disease from lower-income backgrounds who have little access to in-person consultation.

Key Points: 
  • COVID-19 has seen an explosion in telemedicine, with a 40%1 jump in the world's richest countries.
  • WHF believes this digital transformation presents a pivotal opportunity for millions living with cardiovascular disease from lower-income backgrounds who have little access to in-person consultation.
  • "Never before have we seen such a 'techceleration' in cardiology," says Fausto Pinto, President of the World Heart Federation.
  • The general public is encouraged to get involved in World Heart Day by joining the conversation across social platforms using the hashtags #UseHeart and #WorldHeartDay.